In vitro suppression of Herpesvirus saimiri replication by phosphonoacetic acid. 1977

H Barahona, and M D Daniel, and J G Bekesi, and C E Fraser, and N W King, and R D Hunt, and J K Ingalls, and T C Jones

UI MeSH Term Description Entries
D009943 Organophosphorus Compounds Organic compounds that contain phosphorus as an integral part of the molecule. Included under this heading is broad array of synthetic compounds that are used as PESTICIDES and DRUGS. Organophosphorus Compound,Organopyrophosphorus Compound,Organopyrophosphorus Compounds,Compound, Organophosphorus,Compound, Organopyrophosphorus,Compounds, Organophosphorus,Compounds, Organopyrophosphorus
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D003588 Cytopathogenic Effect, Viral Visible morphologic changes in cells infected with viruses. It includes shutdown of cellular RNA and protein synthesis, cell fusion, release of lysosomal enzymes, changes in cell membrane permeability, diffuse changes in intracellular structures, presence of viral inclusion bodies, and chromosomal aberrations. It excludes malignant transformation, which is CELL TRANSFORMATION, VIRAL. Viral cytopathogenic effects provide a valuable method for identifying and classifying the infecting viruses. Cytopathic Effect, Viral,Viral Cytopathogenic Effect,Cytopathic Effects, Viral,Cytopathogenic Effects, Viral,Effect, Viral Cytopathic,Effect, Viral Cytopathogenic,Effects, Viral Cytopathic,Effects, Viral Cytopathogenic,Viral Cytopathic Effect,Viral Cytopathic Effects,Viral Cytopathogenic Effects
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D006564 Herpesviridae A family of enveloped, linear, double-stranded DNA viruses infecting a wide variety of animals. Subfamilies, based on biological characteristics, include: ALPHAHERPESVIRINAE; BETAHERPESVIRINAE; and GAMMAHERPESVIRINAE. Mouse Thymic Virus,Murid herpesvirus 3,Thymic Group Viruses,Herpesviruses,Mouse Thymic Viruses,Thymic Virus, Mouse,Thymic Viruses, Mouse
D006567 Herpesvirus 2, Saimiriine The type species of RHADINOVIRUS, in the subfamily GAMMAHERPESVIRINAE, isolated from squirrel monkeys. It produces malignant lymphomas (LYMPHOMA, MALIGNANT) in inoculated marmosets or owl monkeys. Herpesvirus 2, Saimirine,Herpesvirus 2 (gamma), Saimirine,Herpesvirus Saimiri,Saimiriine Herpesvirus 2,Saimirine Herpesvirus 2,Herpesvirus Saimirus,Saimiri, Herpesvirus,Saimirus, Herpesvirus
D000085 Acetates Derivatives of ACETIC ACID. Included under this heading are a broad variety of acid forms, salts, esters, and amides that contain the carboxymethane structure. Acetate,Acetic Acid Esters,Acetic Acids,Acids, Acetic,Esters, Acetic Acid
D013045 Species Specificity The restriction of a characteristic behavior, anatomical structure or physical system, such as immune response; metabolic response, or gene or gene variant to the members of one species. It refers to that property which differentiates one species from another but it is also used for phylogenetic levels higher or lower than the species. Species Specificities,Specificities, Species,Specificity, Species
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

H Barahona, and M D Daniel, and J G Bekesi, and C E Fraser, and N W King, and R D Hunt, and J K Ingalls, and T C Jones
January 1977, Cancer research,
H Barahona, and M D Daniel, and J G Bekesi, and C E Fraser, and N W King, and R D Hunt, and J K Ingalls, and T C Jones
December 1989, Antiviral research,
H Barahona, and M D Daniel, and J G Bekesi, and C E Fraser, and N W King, and R D Hunt, and J K Ingalls, and T C Jones
January 1980, Archives of virology,
H Barahona, and M D Daniel, and J G Bekesi, and C E Fraser, and N W King, and R D Hunt, and J K Ingalls, and T C Jones
January 1982, Virologie,
H Barahona, and M D Daniel, and J G Bekesi, and C E Fraser, and N W King, and R D Hunt, and J K Ingalls, and T C Jones
January 1982, Virologie,
H Barahona, and M D Daniel, and J G Bekesi, and C E Fraser, and N W King, and R D Hunt, and J K Ingalls, and T C Jones
September 1974, Antimicrobial agents and chemotherapy,
H Barahona, and M D Daniel, and J G Bekesi, and C E Fraser, and N W King, and R D Hunt, and J K Ingalls, and T C Jones
September 1973, Applied microbiology,
H Barahona, and M D Daniel, and J G Bekesi, and C E Fraser, and N W King, and R D Hunt, and J K Ingalls, and T C Jones
February 1984, Journal of virology,
H Barahona, and M D Daniel, and J G Bekesi, and C E Fraser, and N W King, and R D Hunt, and J K Ingalls, and T C Jones
May 1977, Antimicrobial agents and chemotherapy,
H Barahona, and M D Daniel, and J G Bekesi, and C E Fraser, and N W King, and R D Hunt, and J K Ingalls, and T C Jones
January 1991, Advances in cancer research,
Copied contents to your clipboard!